The cancer epigenome - Components and functional correlates

Genes and Development

Volumn 20, Issue 23, 2006, Pages 3215-3231

  Ting, Angela H ^a   McGarvey, Kelly M ^a,b   Baylin, Stephen B ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cancer stem cell; Chromatin modification; DNA methylation; Epigenetics

Indexed keywords

APC PROTEIN; BETA CATENIN; BRCA1 PROTEIN; DNA METHYLTRANSFERASE; HISTONE; SMALL INTERFERING RNA; SOMATOMEDIN B; WNT PROTEIN;

CANCER GENETICS; CANCER GROWTH; CANCER SCREENING; CANCER STEM CELL; CARCINOGENESIS; CHROMATIN; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENOME IMPRINTING; HUMAN; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; STEM CELL;

ANIMALS; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; GENOMIC IMPRINTING; HUMANS; MODELS, GENETIC; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33845417885     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1464906     Document Type: Review

References (233)

1. Aagaard, L., Laible, G., Selenko, P., Schmid, M., Dorn, R., Schotta, G., Kuhfittig, S., Wolf, A., Lebersorger, A., Singh, P.B., et al. 1999. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 18: 1923-1938.
2. Aagaard, L., Schmid, M., Warburton, P., and Jenuwein, T. 2000. Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J. Cell Sci. 113: 817-829.
3. Agoston, A.T., Argani, P., Yegnasubramanian, S., De Marzo, A.M., Ansari-Lari, M.A., Hicks, J.L., Davidson, N.E., and Nelson, W.G. 2005. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J. Biol. Chem. 280: 18302-18310.
4. Akino, K., Toyota, M., Suzuki, H., Mita, H., Sasaki, Y., Ohe-Toyota, M., Issa, J.P., Hinoda, Y., Imai, K., and Tokino, T. 2005. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129: 156-169.
5. Akiyama, Y., Watkins, N., Suzuki, H., Jair, K.W., van Engeland, M., Esteller, M., Sakai, H., Ren, C.Y., Yuasa, Y., Herman, J.G., et al. 2003. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell. Biol. 23: 8429-8439.
6. Bachman, K.E., Rountree, M.R., and Baylin, S.B. 2001. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276: 32282-32287.
7. Bachman, K.E., Park, B.H., Rhee, I., Rajagopalan, H., Herman, J.G., Baylin, S.B., Kinzler, K.W., and Vogelstein, B. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89-95.
8. Bachmann, I.M., Halvorsen, O.J., Collett, K., Stefansson, I.M., Straume, O., Haukaas, S.A., Salvesen, H.B., Otte, A.P., and Akslen, L.A. 2006. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 24: 268-273.
9. Bakin, A.V. and Curran, T. 1999. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283: 387-390.
10. Bakker, J., Lin, X., and Nelson, W.G. 2002. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated π-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 277: 22573-22580.
11. Balkwill, F. and Coussens, L.M. 2004. Cancer: An inflammatory link. Nature 431: 405-406.
12. Ballestar, E. and Esteller, M. 2005. Methyl-CpG-binding proteins in cancer: Blaming the DNA methylation messenger. Biochem. Cell Biol. 83: 374-384.
13. Bannister, A.J., Schneider, R., and Kouzarides, T. 2002. Histone methylation: Dynamic or static? Cell 109: 801-806.
14. Bardwell, V.J. and Treisman, R. 1994. The POZ domain: A conserved protein-protein interaction motif. Genes & Dev. 8: 1664-1677.
15. Bartolomei, M.S. 2003. Epigenetics: Role of germ cell imprinting. Adv. Exp. Med. Biol. 518: 239-245.
16. Bartolomei, M.S. and Tilghman, S.M. 1997. Genomic imprinting in mammals. Annu. Rev. Genet. 31: 493-525.
17. Bartsch, H. and Nair, J. 2005. Accumulation of lipid peroxidation-derived DNA lesions: Potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat. Res. 591: 34-44.
18. Baylin, S.B. and Ohm, J.E. 2006. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6: 107-116.
19. Beach, R., Chan, A.O., Wu, T.T., White, J.A., Morris, J.S., Lunagomez, S., Broaddus, R.R., Issa, J.P., Hamilton, S.R., and Rashid, A. 2005. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am. J. Pathol. 166: 1069-1075.
20. Belinsky, S.A. 2004. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 4: 707-717.
21. Belinsky, S.A., Nikula, K.J., Baylin, S.B., and Issa, J.P. 1996. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. 93: 4045-4050.
22. Belinsky, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S.B., and Herman, J.G. 1998. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. 95: 11891-11896.
23. Belinsky, S.A., Klinge, D.M., Stidley, C.A., Issa, J.P., Herman, J.G., March, T.H., and Baylin, S.B. 2003. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res. 63: 7089-7093.
24. Bernstein, B.E., Humphrey, E.L., Erlich, R.L., Schneider, R., Bouman, P., Liu, J.S., Kouzarides, T., and Schreiber, S.L. 2002. Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl. Acad. Sci. 99: 8695-8700.
25. Bernstein, B.E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D.K., Huebert, D.J., McMahon, S., Karlsson, E.K., Kulbokas III, E.J., Gingeras, T.R., et al. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
26. Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
27. Bestor, T.H. 1998. The host defence function of genomic methylation patterns. Novartis Found. Symp. 214: 187-195; discussion 195-199, 228-232.
28. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes & Dev. 16: 6-21.
29. Bird, A.P. and Wolffe, A.P. 1999. Methylation-induced repression - Belts, braces, and chromatin. Cell 99: 451-454.
30. Bjerkvig, R., Tysnes, B.B., Aboody, K.S., Najbauer, J., and Terzis, A.J. 2005. Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat. Rev. Cancer 5: 899-904.
31. Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353.
32. Bracken, A.P., Pasini, D., Capra, M., Prosperini, E., Colli, E., and Helin, K. 2003. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22: 5323-5335.
33. Briggs, S.D., Xiao, T., Sun, Z.W., Caldwell, J.A., Shabanowitz, J., Hunt, D.F., Allis, C.D., and Strahl, B.D. 2002. Gene silencing: Trans-histone regulatory pathway in chromatin. Nature 418: 498.
34. Bruggeman, S.W., Valk-Lingbeek, M.E., van der Stoop, P.P., Jacobs, J.J., Kieboom, K., Tanger, E., Hulsman, D., Leung, C., Arsenijevic, Y., Marino, S., et al. 2005. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes & Dev. 19: 1438-1443.
35. Burgers, W.A., Fuks, F., and Kouzarides, T. 2002. DNA methyltransferases get connected to chromatin. Trends Genet. 18: 275-277.
36. Cam, H. and Grewal, S.I. 2004. RNA interference and epigenetic control of heterochromatin assembly in fission yeast. Cold Spring Harb. Symp. Quant. Biol. 69: 419-427.
37. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., and Baylin, S.B. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21: 103-107.
38. Carter, M.G., Johns, M.A., Zeng, X., Zhou, L., Zink, M.C., Mankowski, J.L., Donovan, D.M., and Baylin, S.B. 2000. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9: 413-419.
39. Castanotto, D., Tommasi, S., Li, M., Li, H., Yanow, S., Pfeifer, G.P., and Rossi, J.J. 2005. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol. Ther. 12: 179-183.
40. Chen, W.Y., Zeng, X., Carter, M.G., Morrell, C.N., Chiu Yen, R.W., Esteller, M., Watkins, D.N., Herman, J.G., Mankowski, J.L., and Baylin, S.B. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 33: 197-202.
41. Chen, W., Cooper, T.K., Zahnow, C.A., Overholtzer, M., Zhao, Z., Ladanyi, M., Karp, J.E., Gokgoz, N., Wunder, J.S., Andrulis, I.L., et al. 2004. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6: 387-398.
42. Chen, W.Y., Wang, D.H., Yen, R.C., Luo, J., Gu, W., and Baylin, S.B. 2005. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437-448.
43. Chin, H.G., Patnaik, D., Esteve, P.O., Jacobsen, S.E., and Pradhan, S. 2006. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: Participation of the chromodomain in enzymatic catalysis. Biochemistry 45: 3272-3284.
44. Chopra, V.S. and Mishra, R.K. 2005. To SIR with Polycomb: Linking silencing mechanisms. Bioessays 27: 119-121.
45. Coussens, L.M. and Werb, Z. 2002. Inflammation and cancer. Nature 420: 860-867.
46. Cui, H., Cruz-Correa, M., Giardiello, F.M., Hutcheon, D.F., Kafonek, D.R., Brandenburg, S., Wu, Y., He, X., Powe, N.R., and Feinberg, A.P. 2003. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299: 1753-1755.
47. Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., and Pirrotta, V. 2002. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111: 185-196.
48. Darwanto, A., Kitazawa, R., Maeda, S., and Kitazawa, S. 2003. MeCP2 and promoter methylation cooperatively regulate Ecadherin gene expression in colorectal carcinoma. Cancer Sci. 94: 442-447.
49. Datta, J., Ghoshal, K., Sharma, S.M., Tajima, S., and Jacob, S.T. 2003. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. J. Cell. Biochem. 88: 855-864.
50. De Marzo, A.M., Marchi, V.L., Yang, E.S., Veeraswamy, R., Lin, X., and Nelson, W.G. 1999. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59: 3855-3860.
51. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
52. Ebert, A., Schotta, G., Lein, S., Kubicek, S., Krauss, V., Jenuwein, T., and Reuter, G. 2004. Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila. Genes & Dev. 18: 2973-2983.
53. Egger, G., Jeong, S., Escobar, S.G., Cortez, C.C., Li, T.W., Saito, Y., Yoo, C.B., Jones, P.A., and Liang, G. 2006. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. 103: 14080-14085.
54. Eguchi, K., Kanai, Y., Kobayashi, K., and Hirohashi, S. 1997. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history. Cancer Res. 57: 4913-4915.
55. El-Osta, A., Kantharidis, P., Zalcberg, J.R., and Wolffe, A.P. 2002. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22: 1844-1857.
56. Espada, J., Ballestar, E., Fraga, M.F., Villar-Garea, A., Juarranz, A., Stockert, J.C., Robertson, K.D., Fuks, F., and Esteller, M. 2004. Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J. Biol. Chem. 279: 37175-37184.
57. Esteller, M., Silva, J.M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., Bussaglia, E., Prat, J., Harkes, I.C., Repasky, E.A., et al. 2000a. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92: 564-569.
58. Esteller, M., Sparks, A., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M.A., Gonzalez, S., Tarafa, G., Sidransky, D., Meltzer, S.J., et al. 2000b. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60: 4366-4371.
59. Etoh, T., Kanai, Y., Ushijima, S., Nakagawa, T., Nakanishi, Y., Sasako, M., Kitano, S., and Hirohashi, S. 2004. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164: 689-699.
60. Fahrner, J.A., Eguchi, S., Herman, J.G., and Baylin, S.B. 2002. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62: 7213-7218.
61. Feinberg, A.P. 2005. Cancer epigenetics is no Mickey Mouse. Cancer Cell 8: 267-268.
62. Feinberg, A.P. and Tycko, B. 2004. The history of cancer epigenetics. Nat. Rev. Cancer 4: 143-153.
63. Feinberg, A.P. and Vogelstein, B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
64. Feinberg, A.P., Gehrke, C.W., Kuo, K.C., and Ehrlich, M. 1988. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48: 1159-1161.
65. Feinberg, A.P., Ohlsson, R., and Henikoff, S. 2006. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7: 21-33.
66. Ferguson-Smith, A.C. and Surani, M.A. 2001. Imprinting and the epigenetic asymmetry between parental genomes. Science 293: 1086-1089.
67. Finch, P.W., He, X., Kelley, M.J., Uren, A., Schaudies, R.P., Popescu, N.C., Rudikoff, S., Aaronson, S.A., Varmus, H.E., and Rubin, J.S. 1997. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. 94: 6770-6775.
68. Fodde, R., Smits, R., and Clevers, H. 2001. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1: 55-67.
69. Fodor, B.D., Kubicek, S., Yonezawa, M., O'Sullivan, J., Sengupta, R., Perez-Burgos, L., Opravil, S., Mechtler, K., Schotta, G., and Jenuwein, T. 2006. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes & Dev. 20: 1557-1562.
70. Forneris, F., Binda, C., Vanoni, M.A., Mattevi, A., and Battaglioli, E. 2005. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett. 579: 2203-2207.
71. Foster, S.A., Wong, D.J., Barrett, M.T., and Galloway, D.A. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18: 1793-1801.
72. Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37: 391-400.
73. Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R.A., Peinado, M.A., and Clark, S.J. 2006. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. 38: 540-549.
74. Fujii, H., Biel, M.A., Zhou, W., Weitzman, S.A., Baylin, S.B., and Gabrielson, E. 1998. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 16: 2159-2164.
75. Fuks, F., Burgers, W.A., Godin, N., Kasai, M., and Kouzarides, T. 2001. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20: 2536-2544.
76. Furuyama, T., Banerjee, R., Breen, T.R., and Harte, P.J. 2004. SIR2 is required for polycomb silencing and is associated with an E(Z) histone methyltransferase complex. Curr. Biol. 14: 1812-1821.
77. Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X., Parthun, M., and Jacob, S.T. 2002. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol. 22: 8302-8319.
78. Gibbons, R.J. 2005. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14: R85-R92.
79. Gore, S.D., Baylin, S., Sugar, E., Carraway, H., Miller, C.B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J.E., et al. 2006. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res. 66: 6361-6369.
80. Gregorieff, A. and Clevers, H. 2005. Wnt signaling in the intestinal epithelium: From endoderm to cancer. Genes & Dev. 19: 877-890.
81. Grimaud, C., Bantignies, F., Pal-Bhadra, M., Ghana, P., Bhadra, U., and Cavalli, G. 2006. RNAi components are required for nuclear clustering of Polycomb group response elements. Cell 124: 957-971.
82. Gruenbaum, Y., Cedar, H., and Razin, A. 1982. Substrate and sequence specificity of a eukaryotic DNA methylase. Nature 295: 620-622.
83. Guarente, L. 2000. Sir2 links chromatin silencing, metabolism, and aging. Genes & Dev. 14: 1021-1026.
84. Guerardel, C., Deltour, S., Pinte, S., Monte, D., Begue, A., Godwin, A.K., and Leprince, D. 2001. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 276: 3078-3089.
85. Hanahan, D. and Weinberg, R.A. 2000. The hallmarks of cancer. Cell 100: 57-70.
86. Hayashi, M., Tokuchi, Y., Hashimoto, T., Hayashi, S., Nishida, K., Ishikawa, Y., Nakagawa, K., Tsuchiya, S., Okumura, S., and Tsuchiya, E. 2001. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Anticancer Res. 21: 535-540.
87. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O.P., et al. 2001. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344: 539-548.
88. Herman, J.G. and Baylin, S.B. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349: 2042-2054.
89. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R., Linehan, W.M., et al. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. 91: 9700-9704.
90. Hernandez-Munoz, I., Taghavi, P., Kuijl, C., Neefjes, J., and van Lohuizen, M. 2005. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol. Cell. Biol. 25: 11047-11058.
91. Hochedlinger, K., Yamada, Y., Beard, C., and Jaenisch, R. 2005. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477.
92. Holm, T.M., Jackson-Grusby, L., Brambrink, T., Yamada, Y., Rideout III, W.M., and Jaenisch, R. 2005. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8: 275-285.
93. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
94. Issa, J.P. 2004. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4: 988-993.
95. Issa, J.P. 2005. Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: Dose, duration, and patient selection. Nat. Clin. Pract. Oncol. 2 (Suppl. 1): S24-S29.
96. Issa, J.P., Vertino, P.M., Wu, J., Sazawal, S., Celano, P., Nelkin, B.D., Hamilton, S.R., and Baylin, S.B. 1993. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst. 85: 1235-1240.
97. Jackson, J.P., Lindroth, A.M., Cao, X., and Jacobsen, S.E. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416: 556-560.
98. Jackson, J.P., Johnson, L., Jasencakova, Z., Zhang, X., PerezBurgos, L., Singh, P.B., Cheng, X., Schubert, I., Jenuwein, T., and Jacobsen, S.E. 2004. Dimethylation of histone H3 lysine 9 is a critical mark for DNA methylation and gene silencing in Arabidopsis thaliana. Chromosoma 112: 308-315.
99. Jacobs, S.A., Taverna, S.D., Zhang, Y., Briggs, S.D., Li, J., Eissenberg, J.C., Allis, C.D., and Khorasanizadeh, S. 2001. Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. EMBO J. 20: 5232-5241.
100. Jair, K.W., Bachman, K.E., Suzuki, H., Ting, A.H., Rhee, I., Yen, R.W., Baylin, S.B., and Schuebel, K.E. 2006. De novo CpG island methylation in human cancer cells. Cancer Res. 66: 682-692.
101. Janowski, B.A., Huffman, K.E., Schwartz, J.C., Ram, R., Hardy, D., Shames, D.S., Minna, J.D., and Corey, D.R. 2005. Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol. 1: 216-222.
102. Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T., Dombkowski, D.M., Cheng, T., DePinho, R.A., Sharpless, N.E., and Scadden, D.T. 2006. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16(INK4a). Nature 443: 421-426.
103. Jenuwein, T. and Allis, C.D. 2001. Translating the histone code. Science 293: 1074-1080.
104. Johnson, L., Cao, X., and Jacobsen, S. 2002. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol. 12: 1360-1367.
105. Jones, P.A. and Baylin, S.B. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
106. Jones, P.A. and Laird, P.W. 1999. Cancer epigenetics comes of age. Nat. Genet. 21: 163-167.
107. Jones, L., Ratcliff, F., and Baulcombe, D.C. 2001. RNA-directed transcriptional gene silencing in plants can be inherited independently of the RNA trigger and requires Met1 for maintenance. Curr. Biol. 11: 747-757.
108. Kaeberlein, M., McVey, M., and Guarente, L. 1999. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes & Dev. 13: 2570-2580.
109. Kaneda, A. and Feinberg, A.P. 2005. Loss of imprinting of IGF2: A common epigenetic modifier of intestinal tumor risk. Cancer Res. 65: 11236-11240.
110. Kato, Y. and Sasaki, H. 2005. Imprinting and looping: Epigenetic marks control interactions between regulatory elements. Bioessays 27: 1-4.
111. Kawasaki, H. and Taira, K. 2004. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431: 211-217.
112. Kim, G.D., Ni, J., Kelesoglu, N., Roberts, R.J., and Pradhan, S. 2002. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21: 4183-4195.
113. Kimura, A., Umehara, T., and Horikoshi, M. 2002. Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat. Genet. 32: 370-377.
114. Kinzler, K.W. and Vogelstein, B. 1996. Lessons from hereditary colorectal cancer. Cell 87: 159-170.
115. Kirmizis, A., Bartley, S.M., and Farnham, P.J. 2003. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol. Cancer Ther. 2: 113-121.
116. Kirmizis, A., Bartley, S.M., Kuzmichev, A., Margueron, R., Reinberg, D., Green, R., and Farnham, P.J. 2004. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes & Dev. 18: 1592-1605.
117. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A., and Klingelhutz, A.J. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88.
118. Kleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A., Ghosh, D., Sewalt, R.G., Otte, A.P., Hayes, D.F., et al. 2003. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. 100: 11606-11611.
119. Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S., and Shiraishi, M. 2002. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res. 30: 4770-4780.
120. Kondo, Y. and Issa, J.P. 2004. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23: 29-39.
121. Kondo, Y., Shen, L., and Issa, J.P. 2003. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23: 206-215.
122. Krishnamurthy, J., Ramsey, M.R., Ligon, K.L., Torrice, C., Koh, A., Bonner-Weir, S., and Sharpless, N.E. 2006. p16(INK4a) induces an age-dependent decline in islet regenerative potential. Nature 443: 453-457.
123. Krouwels, I.M., Wiesmeijer, K., Abraham, T.E., Molenaar, C., Verwoerd, N.P., Tanke, H.J., and Dirks, R.W. 2005. A glue for heterochromatin maintenance: Stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. J. Cell Biol. 170: 537-549.
124. Kuzmichev, A., Jenuwein, T., Tempst, P., and Reinberg, D. 2004. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14: 183-193.
125. Kuzmichev, A., Margueron, R., Vaquero, A., Preissner, T.S., Scher, M., Kirmizis, A., Ouyang, X., Brockdorff, N., Abate-Shen, C., Farnham, P., et al. 2005. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. 102: 1859-1864.
126. Lacher, M.D., Siegenthaler, A., Jager, R., Yan, X., Hett, S., Xuan, L., Saurer, S., Lareu, R.R., Dharmarajan, A.M., and Friis, R. 2003. Role of DDC-4/sFRP-4, a secreted Frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ. 10: 528-538.
127. Lachner, M. and Jenuwein, T. 2002. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14: 286-298.
128. Lachner, M., O'Sullivan, R.J., and Jenuwein, T. 2003. An epigenetic road map for histone lysine methylation. J. Cell Sci. 116: 2117-2124.
129. Lachner, M., Sengupta, R., Schotta, G., and Jenuwein, T. 2004. Trilogies of histone lysine methylation as epigenetic landmarks of the eukaryotic genome. Cold Spring Harb. Symp. Quant. Biol. 69: 209-218.
130. Laird, P.W. 2003. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3: 253-266.
131. Langley, E., Pearson, M., Faretta, M., Bauer, U.M., Frye, R.A., Minucci, S., Pelicci, P.G., and Kouzarides, T. 2002. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21: 2383-2396.
132. Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M., Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., et al. 2006. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125: 301-313.
133. Lehnertz, B., Ueda, Y., Derijck, A.A., Braunschweig, U., PerezBurgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., and Peters, A.H. 2003. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13: 1192-1200.
134. Lei, H., Oh, S.P., Okano, M., Juttermann, R., Goss, K.A., Jaenisch, R., and Li, E. 1996. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122: 3195-3205.
135. Lessard, J., Schumacher, A., Thorsteinsdottir, U., van Lohuizen, M., Magnuson, T., and Sauvageau, G. 1999. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes & Dev. 13: 2691-2703.
136. Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., Van Lohuizen, M., and Marino, S. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428: 337-341.
137. Li, E., Bestor, T.H., and Jaenisch, R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
138. Lin, S.J., Defossez, P.A., and Guarente, L. 2000. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
139. Lu, H., Ouyang, W., and Huang, C. 2006. Inflammation, a key event in cancer development. Mol. Cancer Res. 4: 221-233.
140. Lund, A. and van Lohuizen, M. 2004a. Polycomb complexes and silencing mechanisms. Curr. Opin. Genet. Dev. 16: 239-246.
141. Lund, A.H. and van Lohuizen, M. 2004b. Epigenetics and cancer. Genes & Dev. 18: 2315-2335.
142. Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. 2001. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107: 137-148.
143. Lyko, F., Ramsahoye, B.H., Kashevsky, H., Tudor, M., Mastrangelo, M.A., Orr-Weaver, T.L., and Jaenisch, R. 1999. Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. Nat. Genet. 23: 363-366.
144. Maison, C., Bailly, D., Peters, A.H., Quivy, J.P., Roche, D., Taddei, A., Lachner, M., Jenuwein, T., and Almouzni, G. 2002. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 30: 329-334.
145. Matsukawa, Y., Semba, S., Kato, H., Ito, A., Yanagihara, K., and Yokozaki, H. 2006. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci. 97: 484-491.
146. McGarvey, K.M., Fahrner, J.A., Greene, E., Martens, J., Jenuwein, T., and Baylin, S.B. 2006. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66: 3541-3549.
147. Melcher, M., Schmid, M., Aagaard, L., Selenko, P., Laible, G., and Jenuwein, T. 2000. Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol. Cell. Biol. 20: 3728-3741.
148. Melki, J.R., Warnecke, P., Vincent, P.C., and Clark, S.J. 1998. Increased DNA methyltransferase expression in leukaemia. Leukemia 12: 311-316.
149. Metzger, E., Wissmann, M., Yin, N., Muller, J.M., Schneider, R., Peters, A.H., Gunther, T., Buettner, R., and Schule, R. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437: 436-439.
150. Molofsky, A.V., Slutsky, S.G., Joseph, N.M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N.E., and Morrison, S.J. 2006. Increasing p16(INK4a) expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443: 448-452.
151. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.W. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790.
152. Morris, K.V., Chan, S.W., Jacobsen, S.E., and Looney, D.J. 2004. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305: 1289-1292.
153. Muller, H.M., Fiegl, H., Goebel, G., Hubalek, M.M., Widschwendter, A., Muller-Holzner, E., Marth, C., and Widschwendter, M. 2003. MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br. J. Cancer 89: 1934-1939.
154. Muyrers-Chen, I., Hernandez-Munoz, I., Lund, A.H., Valk-Lingbeek, M.E., van der Stoop, P., Boutsma, E., Tolhuis, B., Bruggeman, S.W., Taghavi, P., Verhoeven, E., et al. 2004. Emerging roles of Polycomb silencing in X-inactivation and stem cell maintenance. Cold Spring Harb. Symp. Quant. Biol. 69: 319-326.
155. Nagata, M. 2005. Inflammatory cells and oxygen radicals. Curr. Drug Targets Inflamm. Allergy 4: 503-504.
156. Narayan, A., Ji, W., Zhang, X.Y., Marrogi, A., Graff, J.R., Baylin, S.B., and Ehrlich, M. 1998. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer 77: 833-838.
157. Nelson, W.G., De Marzo, A.M., DeWeese, T.L., and Isaacs, W.B. 2004. The role of inflammation in the pathogenesis of prostate cancer. J. Urol. 172: S6-S11. discussion S11-S12
158. Nguyen, C.T., Gonzales, F.A., and Jones, P.A. 2001. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: Correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29: 4598-4606.
159. Nguyen, C.T., Weisenberger, D.J., Velicescu, M., Gonzales, F.A., Lin, J.C., Liang, G., and Jones, P.A. 2002. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62: 6456-6461.
160. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., et al. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561-565.
161. Nuovo, G.J., Plaia, T.W., Belinsky, S.A., Baylin, S.B., and Herman, J.G. 1999. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. 96: 12754-12759.
162. Okano, M., Bell, D.W., Haber, D.A., and Li, E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
163. Orlando, V. 2003. Polycomb, epigenomes, and control of cell identity. Cell 112: 599-606.
164. Paz, M.F., Wei, S., Cigudosa, J.C., Rodriguez-Perales, S., Peinado, M.A.,
165. Pedrali-Noy, G. and Weissbach, A. 1986. Mammalian DNA methyltransferases prefer poly(dI-dC) as substrate. J. Biol. Chem. 261: 7600-7602.
166. Pelissier, T. and Wassenegger, M. 2000. A DNA target of 30 bp is sufficient for RNA-directed DNA methylation. RNA 6: 55-65.
167. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337.
168. Pirrotta, V. and Gross, D.S. 2005. Epigenetic silencing mechanisms in budding yeast and fruit fly: Different paths, same destinations. Mol. Cell 18: 395-398.
169. Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., Otte, A.P., Panning, B., and Zhang, Y. 2003. Role of histone H3 lysine 27 methylation in X inactivation. Science 300: 131-135.
170. Pruitt, K., Zinn, R.L., Ohm, J.E., McGarvey, K.M., Kang, S.H., Watkins, D.N., Herman, J.G., and Baylin, S.B. 2006. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2: 344-352.
171. Radtke, F. and Clevers, H. 2005. Self-renewal and cancer of the gut: Two sides of a coin. Science 307: 1904-1909.
172. Ramsahoye, B.H., Biniszkiewicz, D., Lyko, F., Clark, V., Bird, A.P., and Jaenisch, R. 2000. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. 97: 5237-5242.
173. Rattner, A., Hsieh, J.C., Smallwood, P.M., Gilbert, D.J., Copeland, N.G., Jenkins, N.A., and Nathans, J. 1997. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl. Acad. Sci. 94: 2859-2863.
174. Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B.D., Sun, Z.W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C.P., Allis, C.D., et al. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406: 593-599.
175. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
176. Reynolds, P.A., Sigaroudinia, M., Zardo, G., Wilson, M.B., Benton, G.M., Miller, C.J., Hong, C., Fridlyand, J., Costello, J.F., and Tlsty, T.D. 2006. Tumor suppressor P16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J. Biol. Chem. 281: 24790-24802.
177. Rhee, I., Jair, K.W., Yen, R.W., Lengauer, C., Herman, J.G., Kinzler, K.W., Vogelstein, B., Baylin, S.B., and Schuebel, K.E. 2000. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404: 1003-1007.
178. Rhee, I., Bachman, K.E., Park, B.H., Jair, K.W., Yen, R.W., Schuebel, K.E., Cui, H., Feinberg, A.P., Lengauer, C., Kinzler, K.W., et al. 2002. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556.
179. Rice, J.C., Briggs, S.D., Ueberheide, B., Barber, C.M., Shabanowitz, J., Hunt, D.F., Shinkai, Y., and Allis, C.D. 2003. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12: 1591-1598.
180. Ringrose, L. and Paro, R. 2004. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38: 413-443.
181. Robert, M.F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I.C., Barsalou, A., and MacLeod, A.R. 2003. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33: 61-65.
182. Robertson, K.D. 2005. DNA methylation and human disease. Nat. Rev. Genet. 6: 597-610.
183. Robertson, K.D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F.A., and Jones, P.A. 1999. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27: 2291-2298.
184. Robertson, K.D., Ait-Si-Ali, S., Yokochi, T., Wade, P.A., Jones, P.L., and Wolffe, A.P. 2000. DNMT1 forms a complex with rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25: 338-342.
185. Rountree, M.R., Bachman, K.E., and Baylin, S.B. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25: 269-277.
186. Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C.A., Carter, M.G., de Boom Witzel, S., Okano, H., Ko, M.S., Ohlsson, R., Longo, D.L., and Feinberg, A.P. 2005. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307: 1976-1978.
187. Satoh, A., Toyota, M., Itoh, F., Sasaki, Y., Suzuki, H., Ogi, K., Kikuchi, T., Mita, H., Yamashita, T., Kojima, T., et al. 2003. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res. 63: 8606-8613.
188. Schotta, G., Ebert, A., Krauss, V., Fischer, A., Hoffmann, J., Rea, S., Jenuwein, T., Dorn, R., and Reuter, G. 2002. Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing. EMBO J. 21: 1121-1131.
189. Schotta, G., Ebert, A., and Reuter, G. 2003. SU(VAR)3-9 is a conserved key function in heterochromatic gene silencing. Genetica 117: 149-158.
190. Schwartz, Y.B., Kahn, T.G., Dellino, G.I., and Pirrotta, V. 2004. Polycomb silencing mechanisms in Drosophila. Cold Spring Harb. Symp. Quant. Biol. 69: 301-308.
191. Seligson, D.B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., and Kurdistani, S.K. 2005. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262-1266.
192. Sharpless, N.E. and DePinho, R.A. 2002. p53: Good cop/bad cop. Cell 110: 9-12.
193. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J.R., Cole, P.A., Casero, R.A., and Shi, Y. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953.
194. Shi, Y.J., Matson, C., Lan, F., Iwase, S., Baba, T., and Shi, Y. 2005. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19: 857-864.
195. Silverman, L.R., Demakos, E.P., Peterson, B.L., Kornblith, A.B., Holland, J.C., Odchimar-Reissig, R., Stone, R.M., Nelson, D., Powell, B.L., DeCastro, C.M., et al. 2002. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B. J. Clin. Oncol. 20: 2429-2440.
196. Strahl, B.D. and Allis, C.D. 2000. The language of covalent histone modifications. Nature 403: 41-45.
197. Suka, N., Luo, K., and Grunstein, M. 2002. Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin. Nat. Genet. 32: 378-383.
198. Surani, M.A. 1991. Genomic imprinting: Developmental significance and molecular mechanism. Curr. Opin. Genet. Dev. 1: 241-246.
199. Surani, M.A. 1993. Genomic imprinting. Silence of the genes. Nature 366: 302-303.
200. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G., and Baylin, S.B. 2002. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31: 141-149.
201. Suzuki, H., Watkins, D.N., Jair, K.W., Schuebel, K.E., Markowitz, S.D., Chen, W.D., Pretlow, T.P., Yang, B., Akiyama, Y., Van Engeland, M., et al. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36: 417-422.
202. Suzuki, M., Sunaga, N., Shames, D.S., Toyooka, S., Gazdar, A.F., and Minna, J.D. 2004. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res. 64: 3137-3143.
203. Tamaru, H. and Selker, E.U. 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414: 277-283.
204. Tamaru, H., Zhang, X., McMillen, D., Singh, P.B., Nakayama, J., Grewal, S.I., Allis, C.D., Cheng, X., and Selker, E.U. 2003. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34: 75-79.
205. Tariq, M., Saze, H., Probst, A.V., Lichota, J., Habu, Y., and Paszkowski, J. 2003. Erasure of CpG methylation in Arabidopsis alters patterns of histone H3 methylation in heterochromatin. Proc. Natl. Acad. Sci. 100: 8823-8827.
206. Ting, A.H., Jair, K.W., Suzuki, H., Yen, R.W., Baylin, S.B., and Schuebel, K.E. 2004. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat. Genet. 36: 582-584.
207. Ting, A.H., Schuebel, K.E., Herman, J.G., and Baylin, S.B. 2005. Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet. 37: 906-910.
208. Ting, A.H., Jair, K.W., Schuebel, K.E., and Baylin, S.B. 2006. Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. Cancer Res. 66: 729-735.
209. Tissenbaum, H.A. and Guarente, L. 2001. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227-230.
210. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M.E., Borchers, C.H., Tempst, P., and Zhang, Y. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439: 811-816.
211. Tuck-Muller, C.M., Narayan, A., Tsien, F., Smeets, D.F., Sawyer, J., Fiala, E.S., Sohn, O.S., and Ehrlich, M. 2000. DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients. Cytogenet. Cell Genet. 89: 121-128.
212. Ushijima, T. 2005. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer 5: 223-231.
213. Valenta, T., Lukas, J., Doubravska, L., Fafilek, B., and Korinek, V. 2006. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and β-catenin to the nuclear bodies. EMBO J. 25: 2326-2337.
214. Valk-Lingbeek, M.E., Bruggeman, S.W., and van Lohuizen, M. 2004. Stem cells and cancer; the polycomb connection. Cell 118: 409-418.
215. van 't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
216. Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., Ghosh, D., Pienta, K.J., Sewalt, R.G., Otte, A.P., et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.
217. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L., and Weinberg, R.A. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
218. Vertino, P.M., Yen, R.W., Gao, J., and Baylin, S.B. 1996. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16: 4555-4565.
219. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.M., et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874.
220. Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., and Martienssen, R.A. 2002. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297: 1833-1837.
221. Volpe, T., Schramke, V., Hamilton, G.L., White, S.A., Teng, G., Martienssen, R.A., and Allshire, R.C. 2003. RNA interference is required for normal centromere function in fission yeast. Chromosome Res. 11: 137-146.
222. Wagner, A., Barrows, A., Wijnen, J.T., van der Klift, H., Franken, P.F., Verkuijlen, P., Nakagawa, H., Geugien, M., Jaghmohan-Changur, S., Breukel, C., et al. 2003. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: High mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am. J. Hum. Genet. 72: 1088-1100.
223. Wales, M.M., Biel, M.A., el Deiry, W., Nelkin, B.D., Issa, J.P., Cavenee, W.K., Kuerbitz, S.J., and Baylin, S.B. 1995. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1: 570-577.
224. Wassenegger, M. and Pelissier, T. 1998. A model for RNA-mediated gene silencing in higher plants. Plant Mol. Biol. 37: 349-362.
225. Weisenberger, D.J., Siegmund, K.D., Campan, M., Young, J., Long, T.I., Faasse, M.A., Kang, G.H., Widschwendter, M., Weener, D., Buchanan, D., et al. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38: 787-793.
226. Wu, J., Issa, J.P., Herman, J., Bassett Jr., D.E., Nelkin, B.D., and Baylin, S.B. 1993. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. 90: 8891-8895.
227. Xin, Z., Tachibana, M., Guggiari, M., Heard, E., Shinkai, Y., and Wagstaff, J. 2003. Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. J. Biol. Chem. 278: 14996-15000.
228. Xu, G.L., Bestor, T.H., Bourc'his, D., Hsieh, C.L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J.J., and Viegas-Pequignot, E. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187-191.
229. Yamada, T., Fischle, W., Sugiyama, T., Allis, C.D., and Grewal, S.I. 2005. The nucleation and maintenance of heterochromatin by a histone deacetylase in fission yeast. Mol. Cell 20: 173-185.
230. Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J., and Zhang, Y. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125: 483-495.
231. Yamashita, K., Dai, T., Dai, Y., Yamamoto, F., and Perucho, M. 2003. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4: 121-131.
232. Yan, L., Nass, S.J., Smith, D., Nelson, W.G., Herman, J.G., and Davidson, N.E. 2003. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-α (ER) in ER-negative human breast cancer cell lines. Cancer Biol. Ther. 2: 552-556.
233. Zollman, S., Godt, D., Prive, G.G., Couderc, J.L., and Laski, F.A. 1994. The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc. Natl. Acad. Sci. 91: 10717-10721.